ArticleGene therapy2019

Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells.

Kathleen Broughton et al.PubMed ↗Publisher ↗

No numbers read from the abstract.